Plasma ceramides

1 paper1 finding

Human trial1

Interventions

1

Urolithin a

downin humans1

1 study

Urolithin a decreases plasma ceramides in humans.
“In humans, UA supplementation for 4 months in healthy older adults significantly reduced plasma ceramides clinically validated to predict CVD risks.”
Human trialHealthy older adultsplasma4 months
Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers
iScience14 Jan 2025

More on Urolithin a

Latest

1 in 12 months

Acta Diabetologica4 Aug

Targeted metabolomics identifies associations of plasma ceramides and their ratios with incident type 2 diabetes mellitus

Case-control study of 468 peopleType 2 diabetes

iScience14 Jan

Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers

Trial in peopleUrolithin A